FDA signs on to global CTDs for API manufacturers; Pakistani men charged with shipping illegal drugs;

> The FDA has finally adopted the revised ICH Q11 on drug substance manufacturing, which sets out to create uniformity of common technical documents globally. Story

> The World Health Organization has given its OK to an inexpensive meningitis vaccine, which it says remains safe out of cold storage for four days, helping the supply chain issues in some remote areas. Story

> Japanese drugmaker Takeda Pharmaceutical has appointed Tetsuo Miwa as senior vice president of its pharmaceutical production division. Release

> Members of the Healthcare Distribution Association recorded sales growth at nearly twice the level of pharma manufacturers, the association reports. Release

> A Tennessee pharmacist has been charged with providing a dialysis clinic in Kansas with unapproved iron supplements from China from 2004 to 2009, while claiming that they were getting the FDA-approved Venofer. Release

> Thermo Fisher Scientific has opened a new plant in Suzhou, China, to make products for the pharmaceutical and other industries. Release

And Finally... Two Pakistani men have been charged in the U.S. with illegally shipping $2 million worth of drugs, including steroids and controlled substances, into the U.S. and elsewhere. Release

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.